- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06457009
Impact of Multi-Component Intervention on Suspected Asthma Population (POPMIX-Asthma)
Population Medicine Multimorbidity Intervention in Xishui on a Suspected Asthma Population: A Cluster Randomized Controlled Trial
Study Participants: Suspected asthma population, defined as individuals whose score of asthma screening questionnaire used in ECRHS study exceeds 0 and whose age is 35 and above.
Intervention: Within the intervention arm, we have constructed a population-based pay-for-performance mechanism to encourage medical practitioners to care for population health. For study participants in the intervention arm, we will ask them to finish an online ECRHS questionnaire with notification of his or her suspected asthma status. Individuals whose score of ECRHS asthma screening exceeds 0 will be given a face-to-face survey, simple physical examination, pulmonary function tests, and provide a multi-component intervention at baseline. For suspected asthma population in the intervention arm, we provide community-based spirometry pulmonary function test (PFT) and education; If individuals whose FEV1 improved by ≥12% and ≥200 mL following bronchodilator administration with 400 ug salbutamol, they will be spirometry-defined undiagnosed asthma patient and will be encouraged to seek treatment and medication to the superior hospitals. Additionally, we provide (1) two digital health intervention programs to smokers and individuals with mental health issues; (2) CBT-based health education for study participants with abnormal BMI; (3) active recruitment into National Essential Public Health Program in China for those with abnormal blood pressure and blood glucose. Intensive follow-ups will be conducted at month 3 (telephone interview), month 6 (face-to-face with full steps of physical examination), and month 12.
Comparison: Those who are assigned in the control arm, we will ask them to finish the same ECRHS online questionnaire with notification of his or her suspected asthma status and a face-to-face survey. No physical examinations, community-based pulmonary function tests will be given.
Outcomes: The primary outcomes are asthma knowledge, lung function testing, and ACT score at month 12.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Guizhou
-
Zunyi, Guizhou, China
- Xishui County for Xishui Trial
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 35 and above;
- Score of ECRHS asthma screening questionnaire exceeds 0;
- Residents who have lived in one township over the past 3 months and plan to reside in the same township in the upcoming year;
- Finished the informed consent
Exclusion Criteria:
- Pregnancy and other conditions that are not allowed to finish pulmonary function tests;
- Severe cognitive disorder or total loss of capability of daily living
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm
Within the intervention arm, all medical practitioners will be incentivized by a pay-for-population mechanism within their township.
First, finish a ECRHS questionnaire with notification of suspected asthma risk status.
Those noticed will be given a face-to-face survey, simple physical examination, pulmonary function tests, and provide a multi-component intervention at baseline.
For suspected asthma population, we provide community-based spirometry PFT and education; If individuals whose FEV1 improved by ≥12% and ≥200 mL, they will be undiagnosed asthma patients and encouraged to seek treatment to the superior hospitals.
We provide (1) two digital health intervention programs to smokers and individuals with mental health issues; (2) CBT-based health education for study participants with abnormal BMI; (3) active recruitment into National Essential Public Health Program for those with abnormal blood pressure and glucose.
Intensive follow-ups will be conducted at month 3, 6, 12.
|
|
|
No Intervention: Control Arm
Those who are assigned in the control arm, we will ask them to finish the same ECRHS asthma screening online questionnaire with notification of his or her suspected asthma status and a face-to-face survey.
No physical examinations, community-based pulmonary function tests will be given.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Chronic Diseases Controlled
Time Frame: 1 year
|
Among all objectively measured diseases (asthma, COPD, BMI, hypertensions, type 2 diabetes, depression symptoms, anxiety symptoms), the number of chronic diseases controlled defined by objective measurement at month 12.
|
1 year
|
|
Lung function testing
Time Frame: 1 year
|
Definition: Have you ever had a pulmonary function test?; Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
ACT score
Time Frame: 1 year
|
Definition: Asthma Control Test score Variable type: Continuous; Measurement: Respondent's answer to the question; Introduction to ACT score: Asthma control test (ACT), ranging from 0 to 25, the lower the score, the better asthma controlled.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FEV1 measurement
Time Frame: 1 year
|
Definition: Forced Expiratory Volume in one second (FEV1); Variable type: Continuous; Measurement: Pulmonary function test, portable spirometry;
|
1 year
|
|
Blood pressure
Time Frame: 1 year
|
Definition: Systolic and diastolic blood pressure (mmHg); Variable type: Continuous; Measurement: Omron portable automatic blood pressure monitor;
|
1 year
|
|
Blood Glucose
Time Frame: 1 year
|
Definition: Reference standard for average plasma glucose concentration over a period of time; Variable type: Continuous; Measurement: Blood glucose meter;
|
1 year
|
|
Waist circumference
Time Frame: 1 year
|
Definition: Waist circumference (cm); Variable type: Continuous; Measurement: Soft measuring tape;
|
1 year
|
|
BMI
Time Frame: 1 year
|
Definition: Body mass index (BMI), weight divided by height squared (kg/m²); Variable type: Continuous; Measurement: Calculation;
|
1 year
|
|
T2DM Control
Time Frame: 1 year
|
Definition: Blood glucose within the normal range at the end-of-year follow-up; Variable type: Binary; Measurement: Blood glucose measurement;
|
1 year
|
|
Drinking Status
Time Frame: 1 year
|
Definition: Frequency of alcohol consumption in the past 3 months; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
Sugar Consumption
Time Frame: 1 year
|
Definition: Frequency of consumption of sugary foods/drinks; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
Salted Vegetables Consumption
Time Frame: 1 year
|
Definition: Frequency of consumption of salty vegetables; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
Vegetable Consumption
Time Frame: 1 year
|
Definition: Frequency of consumption of vegetable; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
Bronchial Asthma Screening
Time Frame: 1 year
|
Definition: Have you ever been screened for bronchial asthma by a doctor?
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
Bronchial Asthma Diagnosis
Time Frame: 1 year
|
Definition: Have you ever been diagnosed with bronchial asthma?
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
Bronchial Asthma Treatment
Time Frame: 1 year
|
Definition: Have you followed the treatment therapy from the professional physicians for asthma?
Variable Type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
Bronchial Asthma Control
Time Frame: 1 year
|
Definition: ACT score to categorize whether controlled or not Variable Type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
Family level annual consumption expenditure
Time Frame: 1 year
|
Definition: Annual total household expenditure Variable type: Categorical Measurement: Answer to a question covering local expenditure categories by the household representative
|
1 year
|
|
Employment status
Time Frame: 1 year
|
Definition: Main occupation and type; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
HBP Screening
Time Frame: 1 year
|
Definition: Have you ever had your blood pressure measured by a doctor, nurse, or other healthcare professional?
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
HBP Diagnosis
Time Frame: 1 year
|
Definition: Have you ever been diagnosed with hypertension by a doctor?
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
HBP Treatment
Time Frame: 1 year
|
Definition: Are you currently taking any antihypertensive medication prescribed by a doctor or other healthcare professional?
Variable type: Binary Measurement: Respondent's answer to the question
|
1 year
|
|
HBP Control
Time Frame: 1 year
|
Definition: Blood pressure within the normal range at the end-of-year follow-up; Variable type: Binary; Measurement: Blood pressure measurement;
|
1 year
|
|
T2DM Screening
Time Frame: 1 year
|
Definition: Have you ever had your blood glucose measured by a doctor, nurse, or other healthcare professional?
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
T2DM Diagnosis
Time Frame: 1 year
|
Definition: Have you ever been diagnosed with T2DM by a doctor?
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
T2DM Treatment
Time Frame: 1 year
|
Definition: Are you currently receiving a type 2 diabetes treatment plan prescribed by a doctor or other healthcare professional?
Variable type: Binary Measurement: Respondent's answer to the question
|
1 year
|
|
Smoking Status
Time Frame: 1 year
|
Definition: Do you currently smoke? Variable type: Binary; Measurement: Respondent's answer to the question ; |
1 year
|
|
Smoking Amount
Time Frame: 1 year
|
Definition: How many cigarettes do you smoke per day on average?
Variable type: Count; Measurement: Respondent's answer to the question;
|
1 year
|
|
Self-awareness of COPD
Time Frame: 1 year
|
Definition: Have you ever been diagnosed with COPD?
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
COPD-Knowledge
Time Frame: 1 year
|
Definition: COPD Knowledge Questionnaire(Excerpt); Variable type: Continuous; Measurement: Respondent's answer to the questions;
|
1 year
|
|
Depression Symptoms
Time Frame: 1 year
|
Definition: Emotional disorders, including sadness, loss, and anger; Variable type: Continuous; Measurement: PHQ-9; Introduction to PHQ-9: Patient Health Questionnaire- 9 items (PHQ-9), ranging from 0 to 27, the higher the score, the severer the depression symptoms for the respondents will be.
|
1 year
|
|
Anxiety Symptoms
Time Frame: 1 year
|
Definition: Unpleasant state of inner turmoil; Variable type: Continuous; Measurement: GAD-7; Introduction to GAD-7: General Anxiety Disorder - 7 (GAD-7), ranging from 0 to 21, the higher the score, the severer the anxiety symptoms for the respondents will be.
|
1 year
|
|
Warwick-Edinburgh Mental Well-being Scale, WEM -WBS score
Time Frame: 1 year
|
Definition: Reflects overall mental health problems; Variable type: Continuous; Measurement: WEMWBS; Introduction to WEMWBS: Warwick-Edinburgh Mental Well-being Scale, ranging from 14 to 70, the lower the score, the worse one's general mental health will be.
|
1 year
|
|
Self-rated health status
Time Frame: 1 year
|
Definition: General self-assessed health status; Variable type: Continuous; Measurement: EQ-5D scale; Introduction to EQ-5D-5L scale: The 5-level EQ-5D version (EQ-5D-5L) was introduced by the EuroQol Group in 2009 to improve the instrument's sensitivity and to reduce ceiling effects, as compared to the EQ-5D-3L.
The scale could be transferred to health utility value, ranging from 0 to 1 continuously.
0 represents death and 1 represents perfect health.
|
1 year
|
|
Productivity Loss
Time Frame: 1 year
|
Definition: Productivity loss due to illness or health problems from Working Productivity and Activity Impairment-General Health Chinese version 2.0; Variable type: Continuous; Measurement: Respondent's answer to the question; WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity, i.e., worse outcomes, as follows: Questions:
Scores: Multiply scores by 100 to express in percentages. Percent work time missed due to health: Q2/(Q2+Q4) Percent impairment while working due to health: Q5/10 Percent overall work impairment due to health: Q2/(Q2+Q4)+[(1-(Q2/(Q2+Q4)))x(Q5/10)] Percent activity impairment due to health: Q6/10 |
1 year
|
|
Asthma Knowledge
Time Frame: 1 year
|
Definition: The first 7 questions within Chinese version Patient Asthma Knowledge Questionnaire, the higher the score, the more correct statements the respondents will have chosen. Variable type: Continuous; Measurement: Respondent's answer to the question; |
1 year
|
|
mMRC score
Time Frame: 1 year
|
Definition: score for mMRC questionnaire Variable type: Categorical Measurement: Respondent's answers to the question Introduction to mMRC: Modified Medical Research Council, categorical value, level 0 represents a good respiratory condition, while the maximum level 4 represents a very bad respiratory condition.
|
1 year
|
|
Medical expenditure within a family over the past year
Time Frame: 1 year
|
Definition: Healthcare-related expenditures; Variable type: Continuous; Measurement: Survey data/insurance/outpatient/inpatient data;
|
1 year
|
|
Number of Outpatient Visits
Time Frame: 1 year
|
Definition: Outpatient visits and type of hospital; Variable type: Count; Measurement: Survey data/insurance/outpatient data;
|
1 year
|
|
Number of Inpatient Visits
Time Frame: 1 year
|
Definition: Inpatient visits and type of hospital; Variable type: Count; Measurement: Survey data/insurance/outpatient data;
|
1 year
|
|
Physical exercise
Time Frame: 1 year
|
Definition: Frequency of physical exercise; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
Smoking Dependence
Time Frame: 1 year
|
Fagerström test for nicotine dependence (FTND) is a scale that measures the nicotine dependence of smokers, ranging from 0 to 10, the higher the value, the worse the nicotine dependence will be.
Heaviness Index of Smoking (HIS) could also be calculated using part of the scale, ranging from 0 to 6, and higher score means worse nicotine dependence.
|
1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Simiao Chen, Ph.D., Peking Union Medical College
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAMS&PUMC-IEC-2024-041
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multimorbidity
-
Malin Olsen SyversenOslo University Hospital; Oslo University CollegeRecruiting
-
National Taiwan University HospitalActive, not recruiting
-
Hospital Galdakao-UsansoloHospital del Mar; Instituto de Salud Carlos III; Hospitales Universitarios Virgen... and other collaboratorsCompleted
-
Dartmouth-Hitchcock Medical CenterNational Library of Medicine (NLM)CompletedMultimorbidityUnited States
-
Central Jutland Regional HospitalCompleted
-
McMaster UniversityCompleted
-
Hospital de Clinicas de Porto AlegreNot yet recruitingMultimorbidityBrazil
-
Central Jutland Regional HospitalNot yet recruiting
-
Slagelse HospitalUniversity of CopenhagenRecruiting
-
Johns Hopkins UniversityEnrolling by invitationMultimorbidityUnited States
Clinical Trials on Multi-component Intervention Package
-
Chiba UniversityNovo Nordisk A/S; Delivery Associates; The Behavioural Insights TeamNot yet recruitingObesity | Physical Activity | Childhood Obesity | Nutrition | Quality of Life (QOL)Japan
-
University of LiverpoolOswaldo Cruz Foundation; University of Warwick; National Institute for Health... and other collaboratorsCompletedEncephalitis | Meningitis | Abscess BrainIndia, Brazil, Malawi
-
Can Tho University of Medicine and PharmacyNational Institute of Hygiene and Epidemiology, VietnamActive, not recruitingInfluenza | Health Communication | Vaccination CoverageVietnam
-
Peking Union Medical CollegeChina-Japan Friendship HospitalCompletedChronic Obstructive Pulmonary Disease | Multimorbidity | Population MedicineChina
-
Fangbiao TaoNot yet recruitingMyopia | Mental Health | Cardiovascular Health Status
-
George Washington UniversityCompletedPrEP | HIV Risk PerceptionUnited States
-
University of Southern DenmarkActive, not recruitingNeck Pain | Shoulder Pain | Lifestyle
-
Fangbiao TaoNot yet recruitingEffectiveness of an AI-Enabled Mobile Intervention on Lifestyle Behaviors and Maternal-Infant HealthPrevention | Lifestyle Intervention | Mobile Health Apps | Multi-component Based Behavioral InterventionChina
-
HBSARecruitingBinge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related HarmsUnited States
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted